Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 7, 2013; 19(41): 7078-7088
Published online Nov 7, 2013. doi: 10.3748/wjg.v19.i41.7078
Published online Nov 7, 2013. doi: 10.3748/wjg.v19.i41.7078
Name | Chromosome location | Function | Related gene | Related cancer | References |
Expression level: C1 > C2 > non-cancer | |||||
hsa-miR-196b | 7p15.2 | Tumor suppressor, progression | HOXA, HOXC8 | T-cell ALL, MLL-rearranged leukemia, ALL, stomach, lung, pancreas | 18,19,27,28 |
hsa-miR-135b | 1q32.1 | Tumorigenesis | FOXO1, APC | Leukemia, anaplastic large cell lymphoma, pancreas, colon, prostate, osteosarcoma | 29-31 |
hsa-miR-93 | 7q22.1 | Tumorigenesis, progression, prognosis | E2F1, ZBTB4, FUS1, TP53INP1, ITGB8, VEGFA, CDKN1A | Kidney, breast, colon, liver, stomach, lung, osteosarcoma, adult T-cell leukemia | 17,32-37 |
Expression level: C1 < C2 < non-cancer | |||||
hsa-miR-29c* | 1q32.2 | Prognosis | Malignant pleural mesothelioma | 38 |
- Citation: Lim JY, Yoon SO, Seol SY, Hong SW, Kim JW, Choi SH, Lee JS, Cho JY. Overexpression of miR-196b and HOXA10 characterize a poor-prognosis gastric cancer subtype. World J Gastroenterol 2013; 19(41): 7078-7088
- URL: https://www.wjgnet.com/1007-9327/full/v19/i41/7078.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i41.7078